Gene expression in blood of subjects with Duchenne muscular dystrophy

Brenda Wong, Donald L. Gilbert, Wynn L. Walker, Isaac H. Liao, Lisa Lit, Boryana Stamova, Glen Jickling, Michelle L Apperson, Frank R Sharp

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The objective of this study was to examine RNA expression in blood of subjects with Duchenne muscular dystrophy (DMD). Whole blood was collected into PAX gene tubes and RNA was isolated for 3- to 20-year-old males with DMD (n∈=∈34) and for age- and gender-matched normal healthy controls (n∈=∈21). DMD was confirmed by genetic testing in all subjects. RNA expression was measured on Affymetrix whole-genome human U133 Plus 2.0 GeneChips. Using a Benjamini-Hochberg false discovery rate of 0.05 to correct for multiple comparisons, an unpaired t test for DMD versus controls yielded 10,763 regulated probes with no fold change cutoff, 1,467 probes with >|1.5|-fold change, 191 probes with >|2.0|-fold change, and 59 probes with a >|2.5|-fold change. These genes (probes) separated DMD from controls using cluster analyses. Almost all of the genes regulated in peripheral blood were different from the genes reported to be regulated in diseased muscle of subjects with DMD. It is proposed that the genes regulated in blood of subjects with Duchenne muscular dystrophy are indicative, at least in part, of the immune response to the diseased DMD muscle. The regulated genes might be used to monitor therapy or provide novel targets for immune-directed therapy for DMD.

Original languageEnglish (US)
Pages (from-to)117-125
Number of pages9
JournalNeurogenetics
Volume10
Issue number2
DOIs
StatePublished - Apr 2009

Fingerprint

Duchenne Muscular Dystrophy
Gene Expression
Genes
RNA
Muscles
Genetic Testing
Human Genome
Cluster Analysis

Keywords

  • Blood
  • Immune
  • Microarrays
  • Muscle
  • Muscular dystrophy

ASJC Scopus subject areas

  • Genetics(clinical)
  • Cellular and Molecular Neuroscience
  • Genetics

Cite this

Gene expression in blood of subjects with Duchenne muscular dystrophy. / Wong, Brenda; Gilbert, Donald L.; Walker, Wynn L.; Liao, Isaac H.; Lit, Lisa; Stamova, Boryana; Jickling, Glen; Apperson, Michelle L; Sharp, Frank R.

In: Neurogenetics, Vol. 10, No. 2, 04.2009, p. 117-125.

Research output: Contribution to journalArticle

Wong, Brenda ; Gilbert, Donald L. ; Walker, Wynn L. ; Liao, Isaac H. ; Lit, Lisa ; Stamova, Boryana ; Jickling, Glen ; Apperson, Michelle L ; Sharp, Frank R. / Gene expression in blood of subjects with Duchenne muscular dystrophy. In: Neurogenetics. 2009 ; Vol. 10, No. 2. pp. 117-125.
@article{422407533e4c4a83bd02fdc9a7e52cf4,
title = "Gene expression in blood of subjects with Duchenne muscular dystrophy",
abstract = "The objective of this study was to examine RNA expression in blood of subjects with Duchenne muscular dystrophy (DMD). Whole blood was collected into PAX gene tubes and RNA was isolated for 3- to 20-year-old males with DMD (n∈=∈34) and for age- and gender-matched normal healthy controls (n∈=∈21). DMD was confirmed by genetic testing in all subjects. RNA expression was measured on Affymetrix whole-genome human U133 Plus 2.0 GeneChips. Using a Benjamini-Hochberg false discovery rate of 0.05 to correct for multiple comparisons, an unpaired t test for DMD versus controls yielded 10,763 regulated probes with no fold change cutoff, 1,467 probes with >|1.5|-fold change, 191 probes with >|2.0|-fold change, and 59 probes with a >|2.5|-fold change. These genes (probes) separated DMD from controls using cluster analyses. Almost all of the genes regulated in peripheral blood were different from the genes reported to be regulated in diseased muscle of subjects with DMD. It is proposed that the genes regulated in blood of subjects with Duchenne muscular dystrophy are indicative, at least in part, of the immune response to the diseased DMD muscle. The regulated genes might be used to monitor therapy or provide novel targets for immune-directed therapy for DMD.",
keywords = "Blood, Immune, Microarrays, Muscle, Muscular dystrophy",
author = "Brenda Wong and Gilbert, {Donald L.} and Walker, {Wynn L.} and Liao, {Isaac H.} and Lisa Lit and Boryana Stamova and Glen Jickling and Apperson, {Michelle L} and Sharp, {Frank R}",
year = "2009",
month = "4",
doi = "10.1007/s10048-008-0167-8",
language = "English (US)",
volume = "10",
pages = "117--125",
journal = "Neurogenetics",
issn = "1364-6745",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Gene expression in blood of subjects with Duchenne muscular dystrophy

AU - Wong, Brenda

AU - Gilbert, Donald L.

AU - Walker, Wynn L.

AU - Liao, Isaac H.

AU - Lit, Lisa

AU - Stamova, Boryana

AU - Jickling, Glen

AU - Apperson, Michelle L

AU - Sharp, Frank R

PY - 2009/4

Y1 - 2009/4

N2 - The objective of this study was to examine RNA expression in blood of subjects with Duchenne muscular dystrophy (DMD). Whole blood was collected into PAX gene tubes and RNA was isolated for 3- to 20-year-old males with DMD (n∈=∈34) and for age- and gender-matched normal healthy controls (n∈=∈21). DMD was confirmed by genetic testing in all subjects. RNA expression was measured on Affymetrix whole-genome human U133 Plus 2.0 GeneChips. Using a Benjamini-Hochberg false discovery rate of 0.05 to correct for multiple comparisons, an unpaired t test for DMD versus controls yielded 10,763 regulated probes with no fold change cutoff, 1,467 probes with >|1.5|-fold change, 191 probes with >|2.0|-fold change, and 59 probes with a >|2.5|-fold change. These genes (probes) separated DMD from controls using cluster analyses. Almost all of the genes regulated in peripheral blood were different from the genes reported to be regulated in diseased muscle of subjects with DMD. It is proposed that the genes regulated in blood of subjects with Duchenne muscular dystrophy are indicative, at least in part, of the immune response to the diseased DMD muscle. The regulated genes might be used to monitor therapy or provide novel targets for immune-directed therapy for DMD.

AB - The objective of this study was to examine RNA expression in blood of subjects with Duchenne muscular dystrophy (DMD). Whole blood was collected into PAX gene tubes and RNA was isolated for 3- to 20-year-old males with DMD (n∈=∈34) and for age- and gender-matched normal healthy controls (n∈=∈21). DMD was confirmed by genetic testing in all subjects. RNA expression was measured on Affymetrix whole-genome human U133 Plus 2.0 GeneChips. Using a Benjamini-Hochberg false discovery rate of 0.05 to correct for multiple comparisons, an unpaired t test for DMD versus controls yielded 10,763 regulated probes with no fold change cutoff, 1,467 probes with >|1.5|-fold change, 191 probes with >|2.0|-fold change, and 59 probes with a >|2.5|-fold change. These genes (probes) separated DMD from controls using cluster analyses. Almost all of the genes regulated in peripheral blood were different from the genes reported to be regulated in diseased muscle of subjects with DMD. It is proposed that the genes regulated in blood of subjects with Duchenne muscular dystrophy are indicative, at least in part, of the immune response to the diseased DMD muscle. The regulated genes might be used to monitor therapy or provide novel targets for immune-directed therapy for DMD.

KW - Blood

KW - Immune

KW - Microarrays

KW - Muscle

KW - Muscular dystrophy

UR - http://www.scopus.com/inward/record.url?scp=64149118096&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=64149118096&partnerID=8YFLogxK

U2 - 10.1007/s10048-008-0167-8

DO - 10.1007/s10048-008-0167-8

M3 - Article

C2 - 19067001

AN - SCOPUS:64149118096

VL - 10

SP - 117

EP - 125

JO - Neurogenetics

JF - Neurogenetics

SN - 1364-6745

IS - 2

ER -